 NEW YORK, Jan. 03, 2023 GLOBE NEWSWIRE Intra-Cellular Therapies, Inc. Nasdaq: ITCI, a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system CNS disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, ... The post Intra-Cellular Therapies to Present at the 41st Annual J.P. Morgan Healthcare Conference app... 